COMMUNIQUÉS West-GlobeNewswire

Idera Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides Corporate Update
02/05/2019
EXTON, Pa., May 02, 2019 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (“Idera”) (NASDAQ: IDRA), a clinical-stage biopharmaceutical company focused on the development, and ultimately the commercialization, of [...]
Melinta Therapeutics to Report First Quarter 2019 Financial Results on May 9, 2019
02/05/2019
MORRISTOWN, N.J., May 02, 2019 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company focused on the development and commercialization of novel antibiotics to treat serious bacterial [...]
Adverum Biotechnologies Announces Board Changes
02/05/2019
Independent Directors Rekha Hemrajani, James Scopa and Mark Lupher Added to the Board Patrick Machado Appointed as Board Chair; Paul Cleveland Retires from the Board MENLO PARK, Calif., May 02, 2019 (GLOBE NEWSWIRE) -- [...]
Zafgen to Announce First Quarter 2019 Financial Results
02/05/2019
BOSTON, May 02, 2019 (GLOBE NEWSWIRE) -- Zafgen, Inc. (Nasdaq:ZFGN), a clinical-stage biopharmaceutical company leveraging its proprietary knowledge of MetAP2 systems biology to develop novel therapies for patients [...]
Geron Corporation Reports First Quarter 2019 Financial Results
02/05/2019
MENLO PARK, Calif., May 02, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today reported financial results for the first quarter ended March 31, 2019. As of the quarter-end, the Company had approximately $ [...]
Inspire Medical Systems, Inc. to Present at the Bank of America Merrill Lynch Health Care Conference 2019
02/05/2019
MINNEAPOLIS, May 02, 2019 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative and minimally invasive [...]
Globus Medical Reports First Quarter 2019 Results
02/05/2019
AUDUBON, Pa., May 02, 2019 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced its financial results for the first quarter ended March 31, 2019. Worldwide [...]
Agile Therapeutics Reports First Quarter 2019 Financial Results
02/05/2019
Company Plans to Resubmit Twirla® NDA in Second Quarter of 2019 Cash Expected to Enable Company to Fund Operations into the Fourth Quarter of 2019 PRINCETON, N.J., May 02, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, [...]
Reata Announces Presentation at the Annual CKD3 Chronic Kidney Disease Drug Development Summit
02/05/2019
IRVING, Texas, May 02, 2019 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq: RETA), a clinical-stage biopharmaceutical company, today announced that Colin Meyer, M.D., Reata’s Chief Medical Officer, will present [...]
IRIDEX Announces 2019 First Quarter Financial Results
02/05/2019
MOUNTAIN VIEW, Calif., May 02, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the first quarter ended March 30, 2019. First Quarter Highlights Total revenue of $10.6 [...]
Menlo Therapeutics Reports First Quarter 2019 Financial Results
02/05/2019
REDWOOD CITY, Calif., May 02, 2019 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (NASDAQ: MNLO), a late-stage biopharmaceutical company focused on the development of serlopitant for the treatment of pruritus (itch), today [...]
Conatus Pharmaceuticals Reports First Quarter 2019 Financial Results and Program Updates
02/05/2019
SAN DIEGO, May 02, 2019 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT) today announced financial results for the first quarter ended March 31, 2019, and provided updates on its development programs. [...]
WW Announces First Quarter 2019 Results and Raises Full Year 2019 EPS Guidance
02/05/2019
End of Period Subscribers in Q1 2019 4.6 million, up 1% year-over-year Total Paid Weeks in Q1 2019 up 4% year-over-year Revenues in Q1 2019 of $363 million, down 11%, or 9% on a constant currency basis, year-over-year [...]
Fluidigm Announces First Quarter 2019 Financial Results
02/05/2019
First quarter revenue increased 19 percent to $30.1 million Mass cytometry revenue growth of 110 percent in first quarter Strong mass cytometry and Imaging Mass Cytometry instrument adoption First complete sample-to- [...]
Adamas to Announce First Quarter 2019 Financial Results and Host Conference Call on May 9, 2019
02/05/2019
EMERYVILLE, Calif., May 02, 2019 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced that the company will report 2019 first quarter financial results on Thursday, May 9, 2019, after market [...]
Novavax Reports First Quarter 2019 Financial Results
02/05/2019
Company to Host Conference Call Today at 4:30 p.m. ET GAITHERSBURG, Md., May 02, 2019 (GLOBE NEWSWIRE) -- Novavax, Inc., (Nasdaq: NVAX) today announced its financial results and operational highlights for the first [...]
Alder BioPharmaceuticals® Reports First Quarter 2019 Financial and Operating Results
02/05/2019
- FDA sets eptinezumab PDUFA date of February 21, 2020; launch expected in first quarter of 2020 - - Acute study planned for potential eptinezumab label expansion - - Conference call today at 5:00 p.m. ET - BOTHELL, [...]
Emergent BioSolutions Reports First Quarter 2019 Financial Results
02/05/2019
Reaffirms full year 2019 financial forecast and operational goals Provides Q2 2019 revenue forecast of $200M-$220M GAITHERSBURG, Md., May 02, 2019 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) reported [...]
Assembly Biosciences Announces Changes to Senior Leadership Team
02/05/2019
SAN FRANCISCO, May 02, 2019 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV) and diseases [...]

Pages